Natus Sensory Acquires TheraB Medical

Natus Sensory Acquires Keriton to Expand Connected Newborn Feeding Care Platform

January 28, 2026

Healthcare Services

Natus Sensory, a global newborn and sensory care solutions provider, acquired Keriton, a U.S.-based cloud software innovator for neonatal and pediatric feeding management. The acquisition is intended to integrate Keriton’s feeding safety and lactation workflow platform into Natus Sensory’s Newborn Care portfolio, enabling a more unified connected care ecosystem for NICUs and pediatric care settings.

ArchiMed Acquires Natus Medical Incorporated

July 21, 2022

Medical Devices

ArchiMed, through its MED Platform II fund, completed a take‑private acquisition of Natus Medical Incorporated, with Natus shareholders receiving $33.50 per share. ArchiMed said it will internationalize and grow Natus' neurodiagnostics product portfolio, reinforce R&D, and pursue complementary bolt‑on acquisitions.

NeoLight Acquires Phoenix Technology Group

November 17, 2021

Medical Devices

NeoLight LLC, an Arizona State University spinout and Scottsdale-based newborn medical device company, has acquired Phoenix Technology Group LLC (PTG), a provider of ophthalmic imaging devices and a telemedicine platform for retinopathy of prematurity (ROP) screening. The deal expands NeoLight’s product portfolio to include the Phoenix ICON camera systems and the Phoenix CONNECT telemedicine platform and aims to leverage PTG’s global distribution to accelerate adoption of NeoLight’s Skylife neonatal phototherapy products.

Medtronic Acquires SonarMed

May 10, 2021

Medical Devices

Medtronic plc acquired SonarMed, a Purdue‑bred developer of the SonarMed airway monitoring system, in December 2020. The acquisition adds continuous acoustic airway monitoring technology for neonatal and pediatric ventilation to Medtronic's respiratory/medical surgical portfolio to help detect endotracheal tube obstruction and position in real time.

Novartis Acquires Amblyotech to Develop Digital Therapy for Amblyopia

April 20, 2020

Medical Devices

Novartis has completed the acquisition of Amblyotech, a US-based digital therapeutics software startup, to develop a software-as-a-medical-device (SaMD) for the treatment of amblyopia. Novartis will collaborate with Ubisoft and McGill University to develop engaging games and advance clinical development toward regulatory approval, aiming to expand its ophthalmology digital-therapy capabilities.

BioNTech Acquires Neon Therapeutics

January 16, 2020

Biotechnology

BioNTech SE will acquire Neon Therapeutics, Inc. in an all-stock transaction valued at approximately $67.0 million. Neon, a Cambridge-based developer of neoantigen-targeted T cell therapies, will become a wholly owned subsidiary of BioNTech to expand BioNTech’s T cell therapy capabilities and U.S. presence.